INDEMNIFICATION AGREEMENTIndemnification Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • New York
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of , 2007, by and between WUXI PHARMATECH (CAYMAN) INC., an exempted company duly incorporated and validly existing under the Law of the Cayman Islands (the “Company”), and (the “Indemnitee”), a director of the Company.
SHARE SUBSCRIPTION AGREEMENT among WUXI PHARMATECH (BVI) INC., GENERAL ATLANTIC PARTNERS (BERMUDA), L.P., GAP-W INTERNATIONAL, LLC, GAPSTAR, LLC, GAP COINVESTMENTS III, LLC, GAP COINVESTMENTS IV, LLC, GAP COINVESTMENTS CDA, L.P., GAPCO GMBH & CO. KG,...Share Subscription Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • New York
SHARE SUBSCRIPTION AGREEMENT, dated January 26, 2007 (this “Agreement”), among WuXi PharmaTech (BVI) Inc., a company incorporated and existing under the laws of the British Virgin Islands (the “Company”), General Atlantic Partners (Bermuda), L.P., a Bermuda limited partnership (“GAP LP”), GAP-W International, LLC, a Delaware limited liability company (“GAP-W”), GapStar, LLC, a Delaware limited liability company (“GapStar”), GAP Coinvestments III, LLC, a Delaware limited liability company (“GAP Coinvestments III”), GAP Coinvestments IV, LLC, a Delaware limited liability company (“GAP Coinvestments IV”), GAP Coinvestments CDA, L.P., a Delaware limited partnership (“GAP Coinvestments CDA”), GAPCO GmbH & Co. KG, a German limited partnership (“GmbH Coinvestment”, together with GAP LP, GAP-W, GapStar, GAP Coinvestments III, GAP Coinvestments IV and GAP Coinvestments CDA, collectively, “General Atlantic”), Fidelity Asia Ventures Fund L.P., a Bermuda limited partnership (“Fidelity Ventures”) a
SECOND AMENDED AND RESTATED JOINT VENTURE AGREEMENT relating to WUXI PHARMATECH (BVI) INC.Joint Venture Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • New York
NOW IT IS HEREBY AGREED that the Amended and Restated JV Agreement shall be amended and restated in its entirety as set forth herein, and the Parties hereto further agree as follows:-
NOTE PURCHASE AGREEMENT among WUXI PHARMATECH (BVI) INC., GENERAL ATLANTIC PARTNERS (BERMUDA), L.P., GAP-W INTERNATIONAL, LLC, GAPSTAR, LLC, GAP COINVESTMENTS III, LLC, GAP COINVESTMENTS IV, LLC, GAP COINVESTMENTS CDA, L.P., GAPCO GMBH & CO. KG and J....Note Purchase Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • New York
NOTE PURCHASE AGREEMENT, dated January 26, 2007 (this “Agreement”), among Wuxi PharmaTech (BVI) Inc., a company incorporated and existing under the laws of the British Virgin Islands (the “Company”), General Atlantic Partners (Bermuda), L.P., a Bermuda limited partnership (“GAP LP”), GAP-W International, LLC, a Delaware limited liability company (“GAP-W”), GapStar, LLC, a Delaware limited liability company (“GapStar”), GAP Coinvestments III, LLC, a Delaware limited liability company (“GAP Coinvestments III”), GAP Coinvestments IV, LLC, a Delaware limited liability company (“GAP Coinvestments IV”), GAP Coinvestments CDA, L.P., a Delaware limited partnership (“GAP Coinvestments CDA”), GAPCO GmbH & Co. KG, a German limited partnership (“GmbH Coinvestment” and, together with GAP LP, GAP-W, GapStar, GAP Coinvestments III, GAP Coinvestments IV and GAP Coinvestments CDA, collectively, “General Atlantic”), and J. P. Morgan Securities Ltd., a company incorporated with limited liability under th
WuXi PharmaTech (Cayman) Inc. AND JPMorgan Chase Bank, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS Deposit Agreement Dated as of [DATE], 2007Deposit Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc.
DEPOSIT AGREEMENT dated as of [DATE], 2007 (the “Deposit Agreement”) among WuXi PharmaTech (Cayman) Inc. and its successors (the “Company”), JPMorgan Chase Bank, N.A., as depositary hereunder (the “Depositary”), and all holders from time to time of American Depositary Receipts issued hereunder (“ADRs”) evidencing American Depositary Shares (“ADSs”) representing deposited Shares (defined below). The Company hereby appoints the Depositary as depositary for the Deposited Securities and hereby authorizes and directs the Depositary to act in accordance with the terms set forth in this Deposit Agreement. All capitalized terms used herein have the meanings ascribed to them in Section 1 or elsewhere in this Deposit Agreement. The parties hereto agree as follows:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • Virgin Islands
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of by and between WuXi PharmaTech (BVI) Inc. (the “Company”) and (the “Executive”)(collectively the “Parties”; individually a “Party”).
WUXI PHARMATECH (CAYMAN) INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc.
THIS INCENTIVE STOCK OPTION AGREEMENT (this “Option Agreement”) dated by and between WuXi PharmaTech (Cayman) Inc., a Cayman exempted company (the “Company”), and (the “Grantee”) evidences the incentive stock option (the “Option”) granted by the Company to the Grantee as to the number of shares of the Company’s Ordinary Shares first set forth below.
REGISTRATION RIGHTS AGREEMENT by and among WUXI PHARMATECH (CAYMAN) INC. and THE OTHER PARTIES NAMED HEREINRegistration Rights Agreement • July 24th, 2007 • WuXi PharmaTech (Cayman) Inc. • New York
REGISTRATION RIGHTS AGREEMENT, dated June 4, 2007 (this “Agreement”), among WuXi PharmaTech (Cayman) Inc., a company organized and existing under the laws of the Cayman Islands with its principal office located at P.O. Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands (the “Company”), WuXi PharmaTech (BVI) Inc. with its registered office at P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands (the “Sub”), and the Persons listed on Schedule 1 hereto.
